Syros Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-5.007; its P/E ratio is -1.13; Syros Pharmaceuticals is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-0.77. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Income Statement	-
Total Revenue	-	$ 387.00K	$ 3.76M	$ 2.83M	$ 2.95M
Gross Profit	-	$ 387.00K	$ 3.76M	$ 2.83M	$ 2.95M
EBIT	$ -2.40M	$ -63.02M	$ -38.89M	$ -34.98M	$ -22.57M
EBITDA	$ -2.03M	$ -62.47M	$ -38.28M	$ -34.82M	$ -22.33M
Net Income Common Stockholders	$ -3.71M	$ -64.38M	$ -40.14M	$ -36.26M	$ -23.79M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 108.30M	$ 139.53M	$ 112.22M	$ 143.98M	$ 165.80M
Total Assets	$ 134.73M	$ 168.17M	$ 147.79M	$ 180.98M	$ 205.32M
Total Debt	$ 61.67M	$ 62.08M	$ 62.46M	$ 62.83M	$ 63.17M
Net Debt	$ -46.63M	$ -77.45M	$ -49.76M	$ -81.16M	$ -102.63M
Total Liabilities	$ 119.67M	$ 151.51M	$ 111.49M	$ 107.74M	$ 98.57M
Stockholders Equity	$ 15.06M	$ 16.66M	$ 36.30M	$ 73.22M	$ 106.75M
Cash Flow	-
Free Cash Flow	$ -31.10M	$ -17.04M	$ -31.86M	$ -22.39M	$ -37.14M
Operating Cash Flow	$ -31.10M	$ -18.56M	$ -31.86M	$ -22.39M	$ -36.90M
Investing Cash Flow	$ -24.64M	$ 1.52M	$ 28.64M	$ 32.92M	$ -25.75M
Financing Cash Flow	$ -265.00K	$ 43.38M	$ -5.00K	$ 140.00K	$ -53.00K

Currency in USD

Syros Pharmaceuticals Earnings and Revenue History

Income Statement >

Syros Pharmaceuticals Debt to Assets

Balance Sheet >

Syros Pharmaceuticals Cash Flow

Cash Flow >

Syros Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing